Welcome to our dedicated page for Augmedix news (Ticker: AUGX), a resource for investors and traders seeking the latest updates and insights on Augmedix stock.
Augmedix Inc (AUGX) is a leading telemedicine charting service for healthcare providers, streamlining EHR documentation and saving providers 17 hours weekly. By leveraging wearable technology, Augmedix connects clinics with its charting service, allowing providers to focus on patient care.
Augmedix caters to the ambulatory, clinical, and hospital segments of the U.S. patient care services market, offering products that address medical note documentation needs. Its innovative solutions extract data from natural clinician-patient conversations, converting it in real-time to medical notes that seamlessly integrate with electronic health records (EHR).
The company generates revenue through service fees charged to customers for subscribing to its remote medical documentation and clinical support products. Augmedix is dedicated to empowering clinicians, enhancing care delivery, and improving operational outcomes.
Rhea-AI Summary
Augmedix (Nasdaq: AUGX) has been recognized as one of the World's Best Digital Health Companies 2024 by Newsweek and Statista Inc. The award highlights Augmedix's commitment to empowering clinicians through ambient AI medical documentation solutions. Augmedix's platform converts natural conversations into structured medical notes, enhancing efficiency and clinical decision-making. The company's inclusion in the top 400 companies from over 35 countries is based on financial performance, impact, and online engagement criteria.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.15%
Tags
-
Rhea-AI Summary
Augmedix launches Augmedix Go, the industry’s first fully-automated, GenAI-powered medical documentation product for emergency departments. The product aims to improve patient experience, increase productivity, reduce cognitive burden, and shorten chart closure time. Augmedix Go was piloted with HCA Healthcare EDs, receiving positive feedback on note quality and AI accuracy.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.35%
Tags
-
Rhea-AI Summary
Augmedix (AUGX) partners with Andor Health to enhance virtual care with ambient AI medical documentation, aiming to improve clinician-patient interactions and streamline workflows. The collaboration integrates AI-generated clinical notes within ThinkAndor® Virtual Visit, leveraging ambient documentation to transform care settings. Augmedix and Andor Health aim to optimize communication, reduce clinician burnout, and enhance patient outcomes through their innovative platforms.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1%
Tags
Rhea-AI Summary
Augmedix (AUGX) partners with SADA, an Insight company, to accelerate digital health solutions and integrations. The collaboration aims to enhance ambient AI medical documentation and data products for health systems.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Augmedix (AUGX) reports impressive financial results for Q4 and full year 2023, showcasing revenue growth of 45% to $12.7 million and $44.9 million respectively. The company achieved a gross profit increase of 54% to $6.2 million and $21.5 million for the respective periods. Augmedix anticipates revenue of $60 to $62 million in 2024, reflecting strong growth prospects.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18.92%
Tags
-
Rhea-AI Summary
Augmedix (AUGX) announces positive data and product enhancements for Augmedix Go, saving clinicians up to 1 hour per day in medical documentation. The app supports over 50 medical specialties, generating real-time draft notes from natural conversations. Survey data shows 94% of clinicians report better patient focus. Augmedix Go integrates with major EHRs and uses AI models for high-quality notes. CEO Manny Krakaris emphasizes the need for automated solutions to combat administrative burden and burnout.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5%
Tags
Rhea-AI Summary
Augmedix (Nasdaq: AUGX) to Release Q4 and Full Year 2023 Results on March 18, 2024
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.42%
Tags
-
Rhea-AI Summary
Augmedix, Inc. (Nasdaq: AUGX) will participate in the Citizens JMP Technology Conference in San Francisco on March 4, 2024. The management team will host a fireside chat and investor meetings, accessible through a webcast on the Company's IR website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.43%
Tags
-
Rhea-AI Summary
Augmedix appoints Tomer Levy as Senior Vice President of Engineering to enhance product development and operational efficiency in healthcare technology sector.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.68%
Tags
Rhea-AI Summary
Augmedix, Inc. (AUGX) to participate in Maxim Group Virtual Healthcare IT Conference on January 24, 2024. Manny Krakaris, CEO, to join fireside chat with Allen Klee, Equity Research Analyst. Investors can arrange meetings through FNK IR or Maxim Group representative.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.2%
Tags
FAQ
What is the current stock price of Augmedix (AUGX)?
The current stock price of Augmedix (AUGX) is $2.35 as of October 2, 2024.
What is the market cap of Augmedix (AUGX)?
The market cap of Augmedix (AUGX) is approximately 116.2M.
What does Augmedix (AUGX) offer to healthcare providers?
Augmedix provides a telemedicine charting service that streamlines EHR documentation, saving providers significant time.
How does Augmedix help healthcare organizations?
Augmedix's products extract data from clinician-patient conversations, convert it into medical notes, and seamlessly transfer them to EHR systems.
How does Augmedix generate revenue?
The company charges service fees to customers for subscribing to its remote medical documentation and clinical support products.
What segments of the U.S. patient care services market does Augmedix operate in?
Augmedix caters to the ambulatory, clinical, and hospital segments of the U.S. patient care services market.
What is the core focus of Augmedix's products?
Augmedix's products focus on addressing medical note documentation needs for healthcare organizations, from large hospitals to individual practitioners.
Augmedix, Inc.
Nasdaq:AUGX
AUGX Rankings
AUGX Stock Data
116.16M
48.69M
1.5%
84.78%
2.16%
Health Information Services
Services-business Services, Nec
United States of America
SAN FRANCISCO